Huu Dat Nguyen

Huu Dat Nguyen

Auto-generated profile, based on publicly available information

Huu Dat Nguyen

Department of Neurology Hallym University Sacred Heart Hospital, Hallym University Anyang Republic of Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2023 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
HNHuu Dat Nguyen
Huu Dat Nguyen
YKYoung Eun Kim
Young Eun Kim
LNLinh Thi Nhat Nguyen
Linh Thi Nhat Nguyen
IKIn Hee Kwak
In Hee Kwak
YLYoon Kyoung Lee
Yoon Kyoung Lee
HMHyeo-Il Ma
Hyeo-Il Ma

8 May 2025 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
JYJe Kook Yu
Je Kook Yu
HCHye Joung Choi
Hye Joung Choi
DKDongwoo Kim
Dongwoo Kim
PNPham Hong Ngoc
Pham Hong Ngoc
IKIn Hee Kwak
In Hee Kwak
YKYoung Eun Kim
Young Eun Kim

30 October 2025 in EBioMedicine
Verified
Journal Article
Open access
HNHuu Dat Nguyen
Huu Dat Nguyen
HTHoang Bao Tram Tran
Hoang Bao Tram Tran
TNThanh Trung Nguyen
Thanh Trung Nguyen
IKIn Hee Kwak
In Hee Kwak
YKYun Joong Kim
Yun Joong Kim
YKYoung Eun Kim
Young Eun Kim
Parkinson's disease (PD) is characterised by α-synuclein accumulation and progressive neurodegeneration, with immune activation recognised as a key contributor. The immunoproteasome (IP), particularly its catalytic subunit PSMB8, plays dual roles in proteostasis and immune regulation, yet has an unclear role in synucleinopathies. A total of 232 blood samples from patients with synucleinopathies (PD, multiple system atrophy [MSA], and rapid eye movement [REM] sleep behaviour disorder [RBD]), and healthy individuals were analysed for IP expression/activity in peripheral blood mononuclear cells (PBMCs) and neuronal extracellular vesicles (NEVs), and effects of IP inhibition using flow cytometry. Post-mortem human substantia nigra was examined for spatial distribution of PSMB8. The PD mouse model and human dopaminergic neuron models, combined with transcriptomic analysis, were used to investigate IP changes and inhibition effects. Consistent upregulation of PSMB8 mRNA and protein was found in PBMCs and NEVs from people with PD, and MSA. This was recapitulated across multiple experimental models, including dopaminergic neurons treated with rotenone, carrying the SNCA-A53T, overexpressing α-synuclein, or exposed to α-synuclein preformed fibrils (PFF), as well as PFF-injected mice model. In human PD substantia nigra, PSMB8 was enriched in the core of mature Lewy bodies, revealing its involvement in synucleinopathies. Pharmacological inhibition of PSMB8 reduced α-synuclein accumulation and apoptosis in PD dopaminergic cell model, and decreased CD8+ T cells in PBMCs derived from patients with PD. Notably, α-synuclein clearance did not align with proteasomal or autophagy-lysosomal pathways, but instead correlated with non-proteasomal trypsin-like activity. In the CD8+ T cell-dopaminergic neuron co-culture model that mimics T cell mediated neuronal cytotoxicity, PSMB8 inhibition further improved neuronal survival, lowered intracellular α-synuclein levels, and attenuated CD8+ T cell degranulation, linking neuronal α-synuclein burden to immune-mediated toxicity. These findings identify PSMB8 as a key molecular link between protein aggregation and immune dysregulation in PD, supporting its potential as a therapeutic target for synucleinopathies. This research was funded by the Ministry of Education (RS-2023-00246655), the Ministry of Health & Welfare, Republic of Korea (grant number: RS-2023-00265159), the Korea government (MSIT) (2022R1A2C2091254; RS-2023-00223501).

13 February 2026 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
UMUk Yeol Moon
Uk Yeol Moon
YKYoung Eun Kim
Young Eun Kim
HNHuu Dat Nguyen
Huu Dat Nguyen
HCHYE JOUNG CHOI
HYE JOUNG CHOI
Glutamate-induced oxidative cytotoxicity is a major driver of neuronal loss in neurodegenerative diseases, yet the upstream transcriptional regulators linking oxidative stress to neuronal death remain unclear despite the known involvement of the p53–GADD45α pathway. CREB2 (ATF4) is a stress-responsive transcription factor, but its role in microglia-mediated oxidative neurotoxicity has not been fully defined. Here, we investigated CREB2 function in oxidative glutamate toxicity using HT22 hippocampal neurons, primary mouse hippocampal cells, and a kainic acid (KA)-injected rat model. Oxidative stress was induced by glutamate, intracellular ROS levels were quantified with DCFDA, and the antioxidant N-acetylcysteine (NAC) was used to confirm oxidative dependency. Microglia-derived glutamate was assessed by stimulating BV2 cells with lipopolysaccharide (LPS) and applying glutamate-containing conditioned medium (LPS-CM) to HT22 cells. Exogenous glutamate robustly increased CREB2 expression in HT22 and primary neurons, accompanied by ROS accumulation and cell death, whereas NAC suppressed these effects. Inhibition of p53 by siRNA or pifithrin-α (PFT-α) attenuated glutamate-induced CREB2 upregulation, and CREB2 knockdown blocked GADD45α induction and protected neurons. In Vivo, KA injection caused robust CREB2 upregulation in the damaged CA3 region. Importantly, conditioned medium from LPS-activated BV2 microglia increased CREB2 expression and ROS levels in HT22 cells in an NAC-sensitive manner, supporting a glutamate-associated oxidative mechanism rather than receptor-mediated excitotoxicity. Collectively, these results suggest that CREB2 functions between upstream p53 signaling and downstream GADD45α activation as a redox-sensitive mediator of oxidative neuronal death, and may represent a potential therapeutic target in neurodegenerative diseases associated with oxidative stress and neuroinflammation.

31 January 2026 in Journal of Movement Disorders
Verified
Journal Article
Open access
PDF file
JLJeongjae Lee
Jeongjae Lee
HKHan Joon Kim
Han Joon Kim
HNHuu Dat Nguyen
Huu Dat Nguyen
SSSuk Jun Song
Suk Jun Song
TTTrung Nguyen Thanh
Trung Nguyen Thanh
YKYoung Eun Kim
Young Eun Kim
Objective The NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome has been proposed to be a downstream mediator of neuroinflammation in individuals with Parkinson’s disease (PD). However, its involvement across disease stages and related synucleinopathies, such as multiple system atrophy (MSA), remains unclear. We aimed to analyze the peripheral mRNA expression of NLRP3-related genes and cytokines across individuals with isolated REM sleep behavior disorder (iRBD), early-stage PD, late-stage PD, and MSA.Methods Peripheral blood mononuclear cells (PBMCs) were collected from 151 participants: 35 healthy controls (HCs), 31 patients with iRBD, 41 patients with early-stage PD, 21 patients with late-stage PD, and 23 patients with MSA. mRNA expression was measured using quantitative real-time polymerase chain reaction. Statistical comparisons were performed using analysis of variance (ANOVA) or Welch’s ANOVA, and associations with clinical variables were analyzed through stepwise multiple linear regression.Results NLRP3 expression was significantly lower in patients with iRBD (p=0.0263) and patients with early-stage PD (p= 0.0101) than in HCs. NIMA-related kinase 7 (NEK7) expression progressively decreased across the disease spectrum (HCs vs. patients with early-stage PD, p=0.0008; vs. patients with late-stage PD, p<0.0001). In contrast, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) and caspase-1 were elevated in patients with PD, especially those in the late stages. Levels of patients with MSA resembled those of HCs but differed from those of patients with PD. Interleukin (IL)-1β and IL-18 levels were not significantly different. In patients with early-stage PD, NLRP3 expression was negatively correlated with disease duration, the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale Part II score, and the cognitive score.Conclusion Our findings challenge the prevailing hypothesis that NLRP3 inflammasome activation directly contributes to PD pathogenesis. Instead, the observed increase in ASC and caspase-1 expression suggests the potential involvement of alternative inflammasome pathways during disease progression.

11 August 2026 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
HCHYE JOUNG CHOI
HYE JOUNG CHOI
SSSuk Jun Song
Suk Jun Song
HNHuu Dat Nguyen
Huu Dat Nguyen
TNThanh Trung Nguyen
Thanh Trung Nguyen
HTHoang Bao Tram Tran
Hoang Bao Tram Tran
YKYoung Eun Kim
Young Eun Kim